Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, July 6, 2021
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
[ Tue, Jul 06th 2021
] - WOPRAI
Mon, July 5, 2021
[ Mon, Jul 05th 2021
] - WOPRAI
[ Mon, Jul 05th 2021
] - WOPRAI
[ Mon, Jul 05th 2021
] - WOPRAI
Fri, July 2, 2021
[ Fri, Jul 02nd 2021
] - WOPRAI
[ Fri, Jul 02nd 2021
] - WOPRAI
Anupam Rama Maintained (APLS) at Buy with Increased Target to $101 on, Jul 2nd, 2021
Anupam Rama of JP Morgan, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Increased Target from $91 to $101 on, Jul 2nd, 2021.
Anupam has made no other calls on APLS in the last 4 months.
There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $39 on, Thursday, April 29th, 2021
These are the ratings of the 3 analyists that currently disagree with Anupam
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $85 on, Monday, June 28th, 2021
- Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $82 on, Friday, May 21st, 2021
- Madhu Kumar of "Goldman Sachs" Initiated at Strong Buy and Held Target at $130 on, Friday, April 16th, 2021
